The consumer packaged goods (CPG) industry has struggled to grow over the past decade. That’s partly because companies have tended not to economize when it comes to R&D spending. For example, ...

Early on, the drug substance (DS) manufacturer will provide a wealth of preliminary characterization data. And if the drug is active in early nonclinical and preclinical testing, a larger quantity of ...

In the food and beverage space, the companies that are most in tune with consumers’ demands—and the fastest to act on those demands—have a better chance of capturing the largest share of their markets ...

Appropriate use of sound science applied at critical junctures will improve efficiency in the high-wire act of drug development. Pharmaceutical companies walk a tightrope in early drug development.

Cannabis brands face shelf oversaturation. Executives explain how genetics, formulation, and packaging shape which new ...

Suzanne Jansen, MSc, PharmD, ICON, says early-phase clinical success depends on flexible, simple formulations that support wide dose ranges, matching placebos, and robust stability. Formulations are ...

A product designed for long wear can raise different formulation questions from one focused on a lighter feel or easy application. It is also worth asking how much of the development process a ...

Product formulation has traditionally been viewed as a laboratory function. Scientists developed recipes, validated performance, documented results, and handed products off to manufacturing. While ...

Leukocare is a privately owned, product-focused, clinical-stage biotechnology company founded in 2003 and headquartered in Martinsried/Munich, Germany. The company has been funded since its ...

Please provide your email address to receive an email when new articles are posted on . Formulations suggestive of higher temperature processing were associated with greater benzene concentrations.